Patent 10066233 was granted and assigned to IFF Nutrition & Biosciences on September, 2018 by the United States Patent and Trademark Office.
The present invention relates to the use of one or more cas genes for modulating resistance in a cell against a target nucleic acid or a transcription product thereof.